Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque Psoriasis

Name: Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque Psoriasis
Published: 2016
License: Public Domain

Biocad · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

monoclonal-antibody psoriasis

psoriasis, adalimumab, biosimilar, bcd-057, tumor necrosis factor, monoclonal antibody, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque Psoriasis

Related documents